Coronary Stents Market Revenue, Worth, Size, Segment by Type, Application, Key Companies | FMI

 As of 2022, the Coronary Stents market demand is slated to reach a valuation of US$ 33.36 Million.

The demand for interventional cardiology care is being fueled by the rising prevalence of coronary artery disease. Angioplasty is the first choice of treatment for patients with long-term CAD.

Over the last few years, companies in the cardiovascular diagnostic segment are making major investments in order to introduce innovative coronary stents to capitalize on lucrative opportunities in the interventional vascular devices market. Also, companies are working on key related issues of drug eluting stents and working on a comprehensive model of drug release from these stents and the subsequent uptake of the drug into arterial tissue.

For instance, in the past recent years, Abbott received FDA approval for its bioresorbable heart stent absorb, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the U.S.

Coronary Stents Market Structure Analysis

Tier I companies in the coronary stents market include

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • MicroPort Scientific Corporation
  • C. R. Bard, Inc.
  • Cook Medical

Key Takeaways from Coronary Stents Market Study

  • In terms of raw material, the coronary stents market is expected to witness substantial growth in the next few years. Currently, polymer segment accounts for major share of the global Coronary Stents market.
  • North America has been estimated to dominate the coronary stents market with maximum market share in 2019.
  • The primary trend in the coronary stents market is an increasing number of local manufacturers of coronary stents. Also, growth in interventional cardiology procedures, is an ongoing trend in the coronary stents market.

“Increase in number of cardiac catheterization laboratories and increasing prevalence of cardiovascular diseases are the main factors that will continue to drive the growth of the coronary stents.” says the FMI Analyst.

For more Information @ https://www.futuremarketinsights.com/reports/coronary-stents-market 

Increasing Manufacturing Practices across Low Cost Geographies, Boosts the Coronary Stents Market

Transfer of medical device manufacturing practices across low cost geographies such as India, China, South Africa, ASEAN and other Asian countries is expected to fuel growth of the global coronary stents market. Companies offering hospital supplies are targeting price-sensitive geographies through mergers and acquisitions. Leading manufacturers of coronary stents are acquiring domestic players to gain maximum market share in local markets. Moreover, these companies are focusing on low cost product launches in these region owing to large patient pool belonging to the lower middle income group.

Want more insights?

Coronary Stents Market, a new study from Future Market Insights, provides unparalleled insights on evolution of the Coronary Stents market during 2014 - 2018 and presents demand projections during 2020 - 2026 on the basis of product (drug eluting stents, bare metal stents and bioresorbable vascular stents), raw material (cobalt chromium, stainless steel, platinum-chromium, nickel titanium and polymer), end user (hospitals, public hospitals, private hospitals, ambulatory surgical centers and cardiac catheterization laboratories), across seven prominent regions.

Key Segment

By Raw Material:

  • Cobalt Chromium
  • Stainless Steel
  • Platinum – Chromium
  • Nickel – Titanium
  • Polymer

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

By Region:

  • North America
  • Latin America
  • Brazil
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa (MEA)

By Product:

  • Drug Eluting Stent (DES)
  • Bare Metal Stent (BMS)
  • Bioresorbable Vascular Stent (BVS)

Comments

Post a Comment

Popular posts from this blog

Global Autonomous Crane Market Industry Overview and Competitive Landscape till 2032

  The global   autonomous crane market   net worth is estimated to be around US$ 3,028.7 Mn in 2022 and is anticipated to register at a CAGR of 21.7% from 2022 to 2032. As per the report, the overall valuation of the autonomous crane market is expected to reach up to US$ 21,585.7 Mn by the year 2032. Deployment of the  autonomous crane  at the line of work is found to significantly decrease human errors along with workplace-related injuries. The need for autonomous crane machines is expanding as they assist reduce costs, speed up production, and ultimately increase efficiency. However, it is projected that the surging need for smart and intelligent cranes in the real estate, geology & excavation, maritime transport, and manufacturing industries would support the market's growth globally. Since  cranes  are widely employed in the construction business, sales of automated cranes on the global market are anticipated to rise as well. Additionally, the ...
Read more

Hyperloop Train Market Future Scenario, Key Insights, Top Companies 2033

  The global   hyperloop train market   is anticipated to generate US$ 2.05 Bn in revenue in 2023 and this value is predicted to reach US$ 45 Bn by 2033, by registering a striking CAGR of 36.5% over the forecast period. Although the hyperloop is still in its inception stage, investors, technological businesses, and governments from all over the world are showing a lot of interest in this technology. So, the government organizations of developed and emerging nations are studying the hyperloop transportation technology in their nations and have also begun constructing the tracks as a consequence. The demand for hyperloop trains is anticipated to see explosive growth in the next few years due to rising capital expenditure, a positive outlook from the governments, and an increase in the number of important industry participants. Collaboration with new market entrants, availability of land, and growing attention from governments all over the world are some of the main dri...
Read more

Peptide Therapeutics Market: Creating Opportunity, Demands & Supply, Value Chain & Process- upto 2025

  In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI), the worldwide   peptide therapeutics market share   currently valued at US$ 34.4 billion, is anticipated to grow at a remarkable CAGR of 11% from 2022 to 2025, reaching US$ 47 billion. Peptide therapeutics demand are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases. Rising prevalence of these chronic diseases across the world is further expected to widen the existing patient pool. Therapeutic efficacy of  peptide therapeutics  is relatively superior as compared to other marketed drugs, resulting in their higher adoption among physicians. The global peptide therapeutics market was valued at US$ 25.6 Bn in 2021, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2022-2025). The COVID-19 p...
Read more